Centene Corp vs Sanofi SA — how do they compare? Centene Corp trades at $65 (market cap $32.05B), while Sanofi SA trades at $43.7 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 3.3× Centene Corp's market cap, and Sanofi SA pays a 5.55% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| CNC | SNY | |
|---|---|---|
Market Cap | $32.05B | $104.30B |
Sector | Health | Health |
52-Week High | $68.72 | $52.34 |
52-Week Low | $26.17 | $41.33 |
Enterprise Value | $21.10B | $124.19B |
Dividend Yield | — | 5.55% |
Trailing returns across standard periods
Latest headlines on both assets
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →